Concepedia

Scott Summerfield

SS

Statistics

Publications

34

Citations

2.3K

H-Index

25

Active since

1995

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Pfizer (United States)

GlaxoSmithKline (United States)

Roche (Switzerland)

Bristol-Myers Squibb (United States)

Scott Summerfield is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, pharmacy, and peptide analysis.

Publications per year

1995–2022

34

Publications

34

Influence of Secondary Structure on the Fragmentation of Protonated Peptides

George Tsaprailis, Hari Nair, Árpád Somogyi et al. · Journal of the American Chemical Society · 1999 · 353 citations

, , +15

Central Nervous System Drug Disposition: The Relationship between in Situ Brain Permeability and Brain Free Fraction

Scott Summerfield, Kevin D. Read, David J. Begley et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 284 citations

, , +17

Improving the in Vitro Prediction of in Vivo Central Nervous System Penetration: Integrating Permeability, P-glycoprotein Efflux, and Free Fractions in Blood and Brain

Scott Summerfield, Alexander J. Stevens, Leanne Cutler et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 177 citations

, , +17

Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development

Irena Loryan, Andreas Reichel, Bo Feng et al. · Pharmaceutical Research · 2022 · 151 citations · Full text

, , +14

Toward an improved prediction of human<b><i>in vivo</i></b>brain penetration

Scott Summerfield, Adam Lucas, Rod A. Porter et al. · Xenobiotica · 2008 · 105 citations

, , +13

1–5 of 34